IP Library Granted Patent US 9,358,388
Granted Patent B2
US 9,358,388 · App. 14/326,301 · Granted Jun 7, 2016

Systems and methods for detecting intrathecal penetration

Inventors: Jon Parker (San Jose, CA); James R. Thacker (Homer, AK)
Assignee: Nevro Corporation
A61N1/08A61B5/0538A61N1/0551A61N1/36142
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,358,388
App. No.
14/326,301
Granted
Jun 7, 2016
Kind
B2
Abstract

Systems and methods for detecting intrathecal penetration are disclosed. A method in accordance with one embodiment includes detecting a value corresponding to an impedance of an electrical circuit that in turn includes an electrical contact located within the patient, and patient tissue adjacent to the electrical contact. The method further includes comparing the detected value to a predetermined criterion, and, if the detected value meets the predetermined criterion, identifying penetration of the patient's dura based at least in part on the detected value.

Claims (52)

1. A patient device, comprising:

an impedance detector electrically couplable to an electrical contact carried by a signal delivery device, wherein the signal delivery device carries a plurality of electrical contacts, and wherein the electrical contact is a distal-most electrical contact of the signal delivery device; and

a computer-readable medium operatively coupled to the impedance detector, the computer readable medium having instructions that, when executed, perform the following operations:

receive information from the impedance detector corresponding to an impedance of a circuit that includes the electrical contact and patient tissue adjacent to the electrical contact;

compare the detected impedance to a predetermined criterion; and

if the detected impedance meets the predetermined criterion, provide an indication that the patient's dura has been penetrated.

2. The device of claim 1 , wherein the indication includes an indication presented at a display device.

3. The device of claim 1 , wherein the indication includes an aural indication.

4. The device of claim 1 , wherein the predetermined criterion includes a reference impedance of 50 ohms or less.

5. The device of claim 1 , wherein the predetermined criterion includes a reference impedance of 200 ohms or less.

6. The device of claim 1 , wherein the plurality of electrical contacts includes contacts that are coupleable to a pulse generator to deliver a therapy signal to the patient, and wherein the electrical contact included in the circuit is an additional contact.

7. The device of claim 1 , further comprising the signal delivery device, and wherein the signal delivery device and the electrical contact are coupleable to a pulse generator to deliver a therapy signal to the patient.

8. The device of claim 7 , wherein the pulse generator is an implantable pulse generator.

9. The device of claim 7 , wherein the pulse generator is an external pulse generator.

10. The device of claim 7 , wherein the pulse generator is programmed to deliver a therapy signal at a frequency between 3 kHz and 50 kHz.

11. The device of claim 1 , wherein the computer-readable medium further includes instructions that, when executed, perform the following operation:

if the detected value does not meet the predetermined criterion, provide an indication that the patient's dura has not been penetrated.

12. The device of claim 1 , further comprising the signal delivery device.

13. A patient device, comprising:

an implantable signal delivery device having a rounded tip;

a pair of electrical contacts carried by the signal delivery device; and

an intrathecal penetration detector, the intrathecal penetration detector including:

an impedance detector electrically coupled to the electrical contacts;

a processor;

a display device; and

a computer-readable medium operatively coupled to the impedance detector, the computer readable medium having instructions that, when executed, perform the following operations:

receive information from the impedance detector corresponding to an impedance of a circuit that includes the electrical contacts and patient tissue adjacent to the electrical contacts;

compare the detected impedance to a predetermined criterion; and

if the detected impedance meets the predetermined criterion, provide an indication at the display device that the patient's dura has been penetrated.

14. The device of claim 13 , further comprising a power source coupled to the signal delivery device.

15. The device of claim 13 , wherein one of the electrical contacts forms the rounded tip of the signal delivery device.

16. The device of claim 13 , wherein the predetermined criterion includes a reference impedance of 50 ohms or less.

17. The device of claim 13 , wherein the predetermined criterion includes a reference impedance of 200 ohms or less.

18. The device of claim 13 , wherein the computer-readable medium further includes instructions that, when executed, perform the following operation:

if the detected value does not meet the predetermined criterion, provide an indication that the patient's dura has not been penetrated.

19. The device of claim 13 , wherein the signal delivery device carries a plurality of electrical contacts that are coupleable to a pulse generator to deliver a therapy signal to the patient, and wherein the electrical contacts included in the circuit are special-purpose contacts.

20. The device of claim 13 , wherein the signal delivery device and the electrical contacts are coupleable to a pulse generator to deliver a therapy signal to the patient.

21. A patient device, comprising:

an impedance detector electrically couplable to an electrical contact carried by a signal delivery device; and

a computer-readable medium operatively coupled to the impedance detector, the computer readable medium having instructions that, when executed, perform the following operations:

receive information from the impedance detector corresponding to an impedance of a circuit that includes the electrical contact and patient tissue adjacent to the electrical contact;

compare the detected impedance to a predetermined criterion; and

if the detected impedance meets the predetermined criterion, provide an indication that the patient's dura has been penetrated, wherein the predetermined criterion includes a reference impedance of 50 ohms or less.

22. The device of claim 21 , further comprising the signal delivery device.

23. A patient device, comprising:

an impedance detector electrically couplable to an electrical contact carried by a signal delivery device; and

a computer-readable medium operatively coupled to the impedance detector, the computer readable medium having instructions that, when executed, perform the following operations:

receive information from the impedance detector corresponding to an impedance of a circuit that includes the electrical contact and patient tissue adjacent to the electrical contact;

compare the detected impedance to a predetermined criterion;

if the detected impedance meets the predetermined criterion, provide an indication that the patient's dura has been penetrated; and

if the detected value does not meet the predetermined criterion, provide an indication that the patient's dura has not been penetrated.

24. The device of claim 23 , further comprising the signal delivery device.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA NAME PREVIOUSLY RECORDED ON REEL 033265 FRAME 0899. ASSIGNOR(S) HEREBY CONFIRMS THE RECEIVING PARTY DATA NAME IS NEVRO CORP. Recorded Dec 8, 2016
From: PARKER, JON; THACKER, JAMES R.
To: NEVRO CORP.
Reel/Frame 040854/0007 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2016
From: CRG SERVICING LLC
To: NEVRO CORP.
Reel/Frame 039168/0890 →
ASSIGNMENT AGREEMENT (REAFFIRMATION) Recorded Jun 13, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CRG SERVICING LLC,
Reel/Frame 038984/0865 →
SECURITY INTEREST Recorded Dec 12, 2014
From: NEVRO CORP.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034619/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2014
From: PARKER, JON; THACKER, JAMES R.
To: NEVRO CORPORATION
Reel/Frame 033265/0899 →
Continuity (2)
Division 12895438 · Sep 30, 2010
Related Publication 20150012077A1 · Jan 8, 2015